160 related articles for article (PubMed ID: 21080944)
1. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia.
Huang X; Chen S; Shen Q; Yang L; Li B; Zhong L; Geng S; Du X; Li Y
J Hematol Oncol; 2010 Nov; 3(1):44. PubMed ID: 21080944
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles in BCL11B-siRNA treated malignant T cells.
Huang X; Shen Q; Chen S; Chen S; Yang L; Weng J; Du X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
J Hematol Oncol; 2011 May; 4():23. PubMed ID: 21575156
[TBL] [Abstract][Full Text] [Related]
3. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
[TBL] [Abstract][Full Text] [Related]
4. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
5. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
[TBL] [Abstract][Full Text] [Related]
6. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
7. BCL11B suppression does not influence CD34(+) cell differentiation and proliferation.
Shen Q; Huang X; Chen S; Yang L; Chen S; Li B; Wu X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2012 Nov; 17(6):329-33. PubMed ID: 23168072
[TBL] [Abstract][Full Text] [Related]
8. BCL11B is frequently downregulated in HTLV-1-infected T-cells through Tax-mediated proteasomal degradation.
Permatasari HK; Nakahata S; Ichikawa T; Morishita K
Biochem Biophys Res Commun; 2017 Aug; 490(3):1086-1092. PubMed ID: 28669733
[TBL] [Abstract][Full Text] [Related]
9. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
[TBL] [Abstract][Full Text] [Related]
10. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C
Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
[TBL] [Abstract][Full Text] [Related]
12. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
[TBL] [Abstract][Full Text] [Related]
13. The role of BCL11B in regulating the proliferation of human naive T cells.
Chen S; Huang X; Chen S; Yang L; Shen Q; Zheng H; Li B; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hum Immunol; 2012 May; 73(5):456-64. PubMed ID: 22426257
[TBL] [Abstract][Full Text] [Related]
14. BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.
Fu W; Yi S; Qiu L; Sun J; Tu P; Wang Y
J Invest Dermatol; 2017 Jul; 137(7):1523-1532. PubMed ID: 28288848
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
[TBL] [Abstract][Full Text] [Related]
16. Gga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek's disease tumor cell MSB1.
Zhao C; Li X; Han B; You Z; Qu L; Liu C; Song J; Lian L; Yang N
Sci Rep; 2017 Jun; 7(1):4247. PubMed ID: 28652615
[TBL] [Abstract][Full Text] [Related]
17. Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.
Kurosawa N; Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Isobe M
PLoS One; 2013; 8(1):e55147. PubMed ID: 23383087
[TBL] [Abstract][Full Text] [Related]
18. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
[TBL] [Abstract][Full Text] [Related]
19. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
